T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Broadcom
AVGO
|
+$3.01B |
| 2 |
Gilead Sciences
GILD
|
+$1.25B |
| 3 |
Accenture
ACN
|
+$1.09B |
| 4 |
XYZ
Block, Inc.
XYZ
|
+$1.06B |
| 5 |
Valero Energy
VLO
|
+$1.05B |
Top Sells
| 1 |
NVIDIA
NVDA
|
+$3.94B |
| 2 |
Meta Platforms (Facebook)
META
|
+$1.84B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.47B |
| 4 |
Eli Lilly
LLY
|
+$1.43B |
| 5 |
Tesla
TSLA
|
+$1.4B |
Sector Composition
| 1 | Technology | 30.49% |
| 2 | Healthcare | 13.92% |
| 3 | Financials | 12.27% |
| 4 | Consumer Discretionary | 10.96% |
| 5 | Communication Services | 9.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
651
Willis Towers Watson
WTW
$33B
| $62.7M | 0.01% |
185,413
-752
| -0.4% | -$254K |
|
652
Onto Innovation
ONTO
$5.44B
| $62.5M | 0.01% |
515,169
-8,505
| -2% | -$1.03M |
|
653
T. Rowe Price Growth Stock ETF
TGRW
$880M
| $62.4M | 0.01% |
1,745,001
| – | – |
|
654
Edwards Lifesciences
EW
$45.5B
| $62.3M | 0.01% |
859,694
-2,438,028
| -74% | -$177M |
|
655
First Advantage
FA
$2.75B
| $62.1M | 0.01% |
4,409,427
+2,940,155
| +200% | +$41.4M |
|
656
Celldex Therapeutics
CLDX
$1.62B
| $61.9M | 0.01% |
3,410,499
-146,637
| -4% | -$2.66M |
|
657
Agilent Technologies
A
$34.9B
| $61.7M | 0.01% |
527,416
-572,952
| -52% | -$67M |
|
658
CCC Intelligent Solutions
CCCS
$6.37B
| $61.7M | 0.01% |
6,827,626
-3,009,728
| -31% | -$27.2M |
|
659
T. Rowe Price Dividend Growth ETF
TDVG
$1.07B
| $61.6M | 0.01% |
1,525,001
| – | – |
|
660
Procept Biorobotics
PRCT
$2.07B
| $61.5M | 0.01% |
1,055,762
+341,906
| +48% | +$19.9M |
|
661
Lamar Advertising Co
LAMR
$12.9B
| $61.2M | 0.01% |
537,628
-72,507
| -12% | -$8.25M |
|
662
Apple Hospitality REIT
APLE
$2.98B
| $61.2M | 0.01% |
4,737,665
-3,501,396
| -42% | -$45.2M |
|
663
ON Semiconductor
ON
$19.7B
| $61.1M | 0.01% |
1,502,700
+728,177
| +94% | +$29.6M |
|
664
Simpson Manufacturing
SSD
$7.86B
| $61.1M | 0.01% |
388,778
+2,335
| +0.6% | +$367K |
|
665
Unilever
UL
$154B
| $60.9M | 0.01% |
1,022,450
-210,149
| -17% | -$12.5M |
|
666
StoneX
SNEX
$5.04B
| $60.4M | 0.01% |
790,972
+28,297
| +4% | +$2.16M |
|
667
Exelixis
EXEL
$10.5B
| $59.8M | 0.01% |
1,618,518
-148,323
| -8% | -$5.48M |
|
668
Public Service Enterprise Group
PEG
$41.3B
| $59.6M | 0.01% |
724,434
+10,750
| +2% | +$885K |
|
669
Denali Therapeutics
DNLI
$2.07B
| $59.4M | 0.01% |
4,367,234
+1,308,619
| +43% | +$17.8M |
|
670
Colliers International
CIGI
$8.48B
| $59.3M | 0.01% |
488,731
+30,162
| +7% | +$3.66M |
|
671
Axalta
AXTA
$6.75B
| $59.2M | 0.01% |
1,785,263
+21,290
| +1% | +$706K |
|
672
Beam Therapeutics
BEAM
$2.08B
| $59.1M | 0.01% |
3,026,701
+1,273,559
| +73% | +$24.9M |
|
673
Delta Air Lines
DAL
$39.1B
| $58.9M | 0.01% |
1,349,834
-132,327
| -9% | -$5.77M |
|
|
KRMN
674
Karman Holdings Inc.
KRMN
$8.51B
| $58.8M | 0.01% |
+1,759,356
| New | +$58.8M |
|
675
NiSource
NI
$19.3B
| $58.7M | 0.01% |
1,464,599
-790,913
| -35% | -$31.7M |
|